Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondrial deafness.

Nathan Fischel-Ghodsian1

  • 1Department of Pediatrics, Steven Spielbert Pediatric Research Center, Cedars-Sinai Medical Center, Los Angeles, USA.

Ear and Hearing
|August 19, 2003
PubMed
Summary
This summary is machine-generated.

Mitochondrial DNA mutations are linked to various forms of hearing loss, including non-syndromic and drug-induced types. Understanding these genetic factors is key for prevention and treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pseudouridine synthase 1 deficient mice, a model for Mitochondrial Myopathy with Sideroblastic Anemia, exhibit muscle morphology and physiology alterations.

Scientific reports·2016
Same author

Phenotypic expression of maternally inherited deafness is affected by RNA modification and cytoplasmic ribosomal proteins.

Molecular genetics and metabolism·2009
Same author

Partial activity is seen with many substitutions of highly conserved active site residues in human Pseudouridine synthase 1.

RNA (New York, N.Y.)·2008
Same author

MRPS18CP2 alleles and DEFA3 absence as putative chromosome 8p23.1 modifiers of hearing loss due to mtDNA mutation A1555G in the 12S rRNA gene.

BMC medical genetics·2007
Same author

Pleiotropic effects and compensation mechanisms determine tissue specificity in mitochondrial myopathy and sideroblastic anemia (MLASA).

Molecular genetics and metabolism·2007
Same author

Pus3p- and Pus1p-dependent pseudouridylation of steroid receptor RNA activator controls a functional switch that regulates nuclear receptor signaling.

Molecular endocrinology (Baltimore, Md.)·2006
Same journal

Community-Informed Adaptation of a School-Based Hearing Health Intervention: Formative Evaluation for an Effectiveness-Implementation Trial.

Ear and hearing·2026
Same journal

Hearing Difficulty, Health Literacy, and Poorer Health Among Adults in the United States: 2016 Behavioral Risk Factor Surveillance Study.

Ear and hearing·2026
Same journal

Cultural Differences in Listening Environments Between Hispanic and White Non-Hispanic Cochlear Implant Users.

Ear and hearing·2026
Same journal

Detection of Inner Ear Malformations Based on Simple Anatomical Measurements: A Model Approach.

Ear and hearing·2026
Same journal

Avoiding Cisplatin-Related Hearing Loss, Including Implementing Sodium Thiosulfate as Otoprotectant Into Daily Pediatric Clinical Practice: Proceedings Based on Evidence and Expert Opinion From the Ototoxicity Taskforce of the SIOP Supportive Care Network.

Ear and hearing·2026
Same journal

Quantifying Miscommunications in Triadic Conversations: Effects of Hearing Impairment, Hearing Aids, and Background Noise.

Ear and hearing·2026
See all related articles

Area of Science:

  • Genetics
  • Otolaryngology
  • Mitochondrial Biology

Background:

  • Mitochondrial DNA (mtDNA) mutations are increasingly recognized as a cause of hearing loss.
  • While mtDNA's primary role is energy production, mutations can lead to neuromuscular disorders with hearing impairment.
  • Unexpectedly, mtDNA mutations are also linked to non-syndromic hearing loss and aminoglycoside sensitivity.

Purpose of the Study:

  • To review mitochondrial genetics and associated hearing loss mutations.
  • To describe audiological features and clinical relevance of diagnosing these mutations.
  • To discuss preventive and therapeutic strategies based on genetic and environmental factors.

Main Methods:

  • Review of existing literature on mitochondrial genetics and hearing loss.

Related Experiment Videos

  • Analysis of audiological features associated with specific mtDNA mutations.
  • Discussion of clinical relevance and diagnostic approaches.
  • Exploration of environmental exposures and nuclear-encoded modifier genes.

    • Main Results:

    • Identification of several mtDNA mutations linked to hearing loss.
    • Association of mtDNA mutations with syndromic, non-syndromic, and drug-induced hearing loss.
    • Recognition of acquired mtDNA mutations in presbycusis.
    • Understanding the role of environmental factors and nuclear genes in disease expression.

    Conclusions:

    • Mitochondrial DNA mutations are significant contributors to diverse forms of hearing loss.
    • Clinical expression is modulated by environmental exposures and nuclear-modifying genes.
    • Future strategies require identifying these modifiers and avoiding environmental triggers for prevention and therapy.